Organocatalytic, enantioselective synthesis of VNI: a robust therapeutic development platform for Chagas, a neglected tropical disease
about
VNI cures acute and chronic experimental Chagas diseaseComplexes of Trypanosoma cruzi Sterol 14 -Demethylase (CYP51) with Two Pyridine-based Drug Candidates for Chagas Disease: STRUCTURAL BASIS FOR PATHOGEN SELECTIVITYA convergent synthesis of 1,3,4-oxadiazoles from acyl hydrazides under semiaqueous conditionsEnantioselective Synthesis of D-α-Amino Amides from Aliphatic Aldehydes.VFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis.Enantioselective Addition of Bromonitromethane to Aliphatic N-Boc Aldimines Using a Homogeneous Bifunctional Chiral Organocatalyst.Development of an Intermittent-Flow Enantioselective Aza-Henry Reaction Using an Arylnitromethane and Homogeneous Brønsted Acid-Base Catalyst with Recycle.Cellular response to Trypanosoma cruzi infection induces secretion of defensin α-1, which damages the flagellum, neutralizes trypanosome motility, and inhibits infection.Design or screening of drugs for the treatment of Chagas disease: what shows the most promise?Preparation of (-)-Nutlin-3 using enantioselective organocatalysis at decagram scale.Enantioselective methodologies using N-carbamoyl-imines.Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.Enantioselective Synthesis of β-Fluoro Amines via β-Amino α-Fluoro Nitroalkanes and a Traceless Activating Group Strategy.A convergent, scalable and stereoselective synthesis of azole CYP51 inhibitors.
P2860
Q24604994-E192C45A-AA0E-4795-8601-24A0DAE2E581Q27679983-4658ED84-9AA3-4FBA-A695-58330C8E2ABEQ33630686-75662974-2229-4431-99C2-C01267804154Q35230001-7B02CAF8-8B72-48F5-B118-76CC8E76BCFFQ36148993-CC98ADBC-2F6B-4761-9BFB-19D65A1F1BCBQ36728394-4FEB079A-B413-4739-8AC3-BB4D4AD8B56BQ36767080-65E235D4-5BDB-4F65-8F3D-79B8B94E71B3Q37264811-4EC95F16-2DE7-4BFA-9295-74850E992733Q37401820-C9CF785B-72E6-4D46-BA62-964880B65B4FQ37433613-7F7AAD0D-A46D-4275-BEF6-C970B7472E7AQ38159518-E4364EF0-FF4D-4FDD-800C-3CCFB7634B45Q40342687-52C96F68-ADBA-4FB8-8231-B3A90549F42BQ48974117-C41CC40D-98BB-4615-B2CC-0EE320BF1954Q49679428-35443FC8-3F58-400D-9A3D-CAFE7409806C
P2860
Organocatalytic, enantioselective synthesis of VNI: a robust therapeutic development platform for Chagas, a neglected tropical disease
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Organocatalytic, enantioselect ...... , a neglected tropical disease
@ast
Organocatalytic, enantioselect ...... , a neglected tropical disease
@en
Organocatalytic, enantioselect ...... , a neglected tropical disease
@nl
type
label
Organocatalytic, enantioselect ...... , a neglected tropical disease
@ast
Organocatalytic, enantioselect ...... , a neglected tropical disease
@en
Organocatalytic, enantioselect ...... , a neglected tropical disease
@nl
prefLabel
Organocatalytic, enantioselect ...... , a neglected tropical disease
@ast
Organocatalytic, enantioselect ...... , a neglected tropical disease
@en
Organocatalytic, enantioselect ...... , a neglected tropical disease
@nl
P2093
P2860
P921
P356
P1433
P1476
Organocatalytic, enantioselect ...... , a neglected tropical disease
@en
P2093
Fernando Villalta
Galina I Lepesheva
Mark C Dobish
Michael R Waterman
P2860
P304
P356
10.1021/OL303092V
P407
P577
2012-12-07T00:00:00Z